Joe Betts-LaCroix. “How Retro Biosciences Will Add 10 Years to Healthy Human Lifespan”
Join us for a fireside chat between Joe Betts-LaCroix, CEO of Retro Biosciences, and Regis Kelly, former QB3 executive director and currently Bakar Labs director of public outreach.
Register for the Livestream
About the Speaker
Joe Betts-LaCroix is CEO of Retro Biosciences, a company developing therapies for aging-related diseases.
He is a scientist and entrepreneur celebrated for his contributions to biophysics and technology. Raised in Oregon, Joe began his unconventional journey with a “D average” in school, followed by six years immersed in a shared house with artists and musicians. Transitioning to Harvard, he excelled with “straight A’s” in environmental geoscience.
With academic stints at MIT and Caltech, Joe made groundbreaking advancements in ocean research and biophysics, publishing a seminal Science paper on electron-transfer rates in proteins. Co-founding OQO in 2000, he played a key role in creating the world’s smallest Windows PC. Joe’s Silicon Valley endeavors included mentoring startups and advocating for self-experimentation in the Quantified Self movement.
In 2010, he led automation efforts at Halcyon Molecular, supported by Elon Musk and Peter Thiel. Recognizing the need to prioritize age-related diseases, Joe founded the Health Extension Foundation in 2012. Co-founding Vium in 2013 and later Retro Biosciences in 2020, he focuses on developing therapies for aging-related diseases, backed by $180 million in funding from OpenAI CEO Sam Altman. As Retro’s CEO, Joe pioneers innovations in autophagy, blood plasma rejuvenation, and partial cell reprogramming, contributing significantly to the quest for extending healthy human lifespans.
